(Q40473290)

20 September 2017

title

Cancer statistics: Breast cancer in situ. (English)

1 reference

20 September 2017

0 references

Elizabeth M Ward

1

1 reference

20 September 2017

Carol E DeSantis

2

1 reference

20 September 2017

Chun Chieh Lin

3

1 reference

20 September 2017

Joan L Kramer

4

1 reference

20 September 2017

Ahmedin Jemal

5

1 reference

20 September 2017

Betsy Kohler

6

1 reference

20 September 2017

Otis W Brawley

7

1 reference

20 September 2017

Ted Gansler

8

1 reference

20 September 2017

language of work or name

English

0 references

publication date

2 October 2015

1 reference

20 September 2017

1 reference

20 September 2017

volume

65

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

481-495

1 reference

Current management of lesions associated with an increased risk of breast cancer

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Ductal carcinoma in situ (DCIS): raising signposts on an ill-marked treatment path

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Ductal carcinoma in situ: terminology, classification, and natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

The natural history of ductal carcinoma in situ of the breast: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Breast conserving therapy for DCIS--does size matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Atypical ductal hyperplasia: interobserver and intraobserver variability

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Diagnostic concordance among pathologists interpreting breast biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

William Hunter Harridge Lecture: Contemporary management of pre-invasive and early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Radiation therapy for ductal carcinoma in situ: a decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

The Impact of Surgery on Ductal Carcinoma In Situ Outcomes: The Use of Mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Social and Clinical Determinants of Contralateral Prophylactic Mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Disparities in reconstruction rates after mastectomy for ductal carcinoma in situ (DCIS): patterns of care and factors associated with the use of breast reconstruction for DCIS compared with invasive cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

The impact of systemic therapy following ductal carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Choosing Treatment for Patients With Ductal Carcinoma In Situ: Fine Tuning the University of Southern California/Van Nuys Prognostic Index

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ result

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Lobular neoplasia: morphology, biological potential and management in core biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Pleomorphic lobular carcinoma in situ of the breast: Can the evidence guide practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Genetic predisposition to in situ and invasive lobular carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Mammographic density and risk of breast cancer by age and tumor characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Atypical hyperplasia of the breast--risk assessment and management options

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Effects of menopausal hormone therapy on ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Carcinoma In Situ Outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Exemestane for breast-cancer prevention in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

American Cancer Society guidelines for breast cancer screening: update 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Epidemiology of Ductal Carcinoma In Situ

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Update on mammography trends: comparisons of rates in 2000, 2005, and 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Mammographic performance in a population-based screening program: before, during, and after the transition from screen-film to full-field digital mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

The decrease in breast-cancer incidence in 2003 in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Changes in Invasive Breast Cancer and Ductal Carcinoma In Situ Rates in Relation to the Decline in Hormone Therapy Use

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Regulation of in situ to invasive breast carcinoma transition

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

The microenvironment in breast cancer progression: biology and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Knowledge, satisfaction with information, decisional conflict and psychological morbidity amongst women diagnosed with ductal carcinoma in situ (DCIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Communication between patients and providers and informed decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

Quality-of-Life Issues in Patients With Ductal Carcinoma In Situ

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21321

21 January 2018

Identifiers

DOI

10.3322/CAAC.21321

1 reference

release_t2bife352rhy7cko74aeo66emq

20 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t2bife352rhy7cko74aeo66emq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference